New Key Statistics Module, Z-Score and F-Score
FRA:NUR Key Ratios
| Market Cap € M | 137.09 |
| Enterprise Value € M | 539.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.16 |
| Price/Sales | 3.05 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 45.00 |
| EPS (TTM) € | -0.42 |
| Beneish M-Score | -2.85 |
| 10-y EBITDA Growth Rate % | -3.20 |
| 5-y EBITDA Growth Rate % | 11.10 |
| y-y EBITDA Growth Rate % | -23.60 |
| EV-to-EBIT | 90.93 |
| EV-to-EBITDA | 24.23 |
| PEG | -- |
| Shares Outstanding M | 12.85 |
| Net Margin (%) | -12.52 |
| Operating Margin % | -4.73 |
| Pre-tax Margin (%) | -14.82 |
| Quick Ratio | 1.39 |
| Current Ratio | 1.39 |
| ROA % (ttm) | -0.91 |
| ROE % (ttm) | -4.90 |
| ROIC % (ttm) | -0.31 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.30 |
FRA:NUR Number of Guru Trades
FRA:NUR Volume of Guru Trades
Gurus Latest Trades with FRA:NUR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:NUR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers